secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2026-06-17T20:05:18+00:00
Accession:  0001493152-26-029078
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IMDX shareholders approve equity plan amendment increasing authorized shares to 5.55M
--------------------------------------------------------------------------------

- Shareholders voted to increase authorized shares under the 2018 equity plan by 1,750,000 to a total of 5,550,000 shares.
- Four directors re-elected: Joshua Riggs, Andrew Arno, Andrew J. Last, and Louis E. Silverman.
- Appointment of CBIZ CPAs P.C. as independent auditor for FY2026 ratified by shareholders.
- Non-binding advisory 'say-on-pay' proposal for 2025 executive compensation approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315226029078/0001493152-26-029078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315226029078/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-029078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer